Juan Pablo Maianti

Juan Pablo Maianti is currently an Assistant Professor at the Albert Einstein College of Medicine since August 2022. As a co-founder and Employee 001 at Exo Therapeutics, a role held since September 2018, Juan Pablo has contributed significantly to the field. Prior experience includes serving as a Postdoctoral Researcher at the Broad Institute of MIT and Harvard from May 2015 to December 2018 and completing a PhD in Chemistry and Chemical Biology at Harvard University from August 2010 to May 2015, with a thesis focused on the therapeutic potential of Insulin-Degrading Enzyme. Earlier academic credentials include a Master's degree in Synthetic Organic Chemistry from Université de Montréal and a Bachelor's degree in Biochemistry from the University of Canterbury.